AU2001290031A1 - Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes - Google Patents

Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes

Info

Publication number
AU2001290031A1
AU2001290031A1 AU2001290031A AU2001290031A AU2001290031A1 AU 2001290031 A1 AU2001290031 A1 AU 2001290031A1 AU 2001290031 A AU2001290031 A AU 2001290031A AU 2001290031 A AU2001290031 A AU 2001290031A AU 2001290031 A1 AU2001290031 A1 AU 2001290031A1
Authority
AU
Australia
Prior art keywords
vaccination
reverse transcriptase
diagnostic purposes
hiv reverse
mutated peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290031A
Inventor
Brigitte Autran
Vincent Calvez
Patrice Debre
Gaby Haas
Christine Katlama
I Assia Samr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Pierre et Marie Curie Paris 6
Original Assignee
Universite Pierre et Marie Curie Paris 6
Filing date
Publication date
Application filed by Universite Pierre et Marie Curie Paris 6 filed Critical Universite Pierre et Marie Curie Paris 6
Publication of AU2001290031A1 publication Critical patent/AU2001290031A1/en
Abandoned legal-status Critical Current

Links

AU2001290031A 2001-09-14 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes Abandoned AU2001290031A1 (en)

Publications (1)

Publication Number Publication Date
AU2001290031A1 true AU2001290031A1 (en) 2003-04-01

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002344596A1 (en) Tubular titanium oxide particles, method for preparing the same, and use of the same
EP1374935A4 (en) Medical syringe, and method of producing the same
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
WO2003023008A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2001288101A1 (en) Ultrasonic beauty treatment probe
AU2003271021A1 (en) Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof
AU2002312315A1 (en) Microfabricated surgical devices and methods of making the same
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU2002356534A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002228347A1 (en) Malaria plasmodium antigen polypeptide SE36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen
WO2003000733A3 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
AU2003302375A1 (en) Artificial joint, medical implant, and methods of producing the artificial joint and medical implant
AU2002334781A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2003300870A1 (en) Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same
AU2001290031A1 (en) Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
WO2003040330A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003242360A1 (en) Culture apparatus, artificial tissue and blood preparation
AU2002322301A1 (en) Methods for the diagnosis and treatment of cardiac tissue rejection
AU2002309646A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2003083039A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002364696A1 (en) Crystalline neutrokine-alpha protein, method of preparation thereof, and method of use thereof
AU2001289930A1 (en) Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis
AU2001240820A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
WO2003023002A9 (en) Novel human proteins, polynucleotides encoding them and methods of using the same